pigmentary disorders

Aesthetic Concerns in the Hispanic Patient
213512135121351Aesthetic ConcernsNext Steps in Derm, in partnership with Skin of Color Update, interviewed dermatologist Dr. Noelani Gonzalez, clinical instructor at Mount Sinai. Hispanic patients can be of a variety of Fitzpatrick skin types with different and unique aesthetic features. Hear from Dr. Gonzalez as she shares about the aesthetic issues that are more common in Hispanic patients. Find out her tips for assessing and …
Aesthetic Concerns
Laser-Assisted Drug Delivery
205582055820558laser assisted drug deliveryNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Jill S. Waibel, subsection chief of dermatology at Baptist Hospital of Miami, medical director of the Miami Cancer Institute’s Multispecialty Skin Cancer Clinic, and assistant voluntary professor at the University of Miami Miller School of Medicine. Learn about the emerging field of laser-assisted dru …
laser assisted drug delivery
Vitiligo Surgical Treatment Advances
204862048620486VitiligoNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, interviewed Dr. Iltefat Hamzavi, a dermatologist with Henry Ford Health and associate professor of dermatology at Wayne State University School of Medicine. Learn from Dr. Hamzavi the key pillars of vitiligo treatment, and why there’s room to improve available options for melanocyte recruitment and repair. Dr. Hamza …
Vitiligo
Using Superficial Chemical Peels to Treat Pigmentary Disorders
203932039320393superficial chemical peelsNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, interviewed Dr. Heather Woolery-Lloyd, director of the Skin of Color Division for the University of Miami Department of Dermatology. Watch as Dr. Woolery-Lloyd outlines the role of superficial chemical peels in treating pigmentary disorders. Learn how chemical peels impact other treatments. Find out her chemical peel …
superficial chemical peels
Topical Ruxolitinib Therapeutic Cheat Sheet
202782027820278RuxolitinibRuxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …
Ruxolitinib